Navigation Links
p53, tumor suppression and aging

In the January 1 issue of Genes & Development, Dr. Mary Ellen Perry and colleagues validate the p53 inhibitor, Mdm2, as a promising target for cancer therapies.

The p53 tumor suppressor plays a critical role in cancer formation, and many anticancer strategies aim to activate p53 in order to curb tumor formation. Mdm2 is a key inhibitor of p53 and therefore an attractive target to modulate p53 activity in cells. However, conflicting evidence exists regarding whether or not p53-mediated tumor suppression comes at the cost of accelerated aging.

To analyze the effects of reduced Mdm2 levels on tumorigenesis ?as well as the potential for unwanted side effects ?Dr. Perry's team used mdm2-hypomorphic mice (that express less Mdm2 protein than normal mice) which have elevated levels of wild-type p53 activity. The researchers found that even a modest decrease (about 20%) in Mdm2 effectively prevents tumor formation and does not lead to premature aging.

Dr. Perry emphasizes that "many people develop cancer at a young age due to increased expression of Mdm2. The possibility that inhibitors of Mdm2 could delay cancer in such people without causing detrimental side effects is bolstered by our demonstration that mice expressing 30-80% the normal level of Mdm2 develop fewer tumors than wild type mice, yet age normally."


'"/>

Source:Cold Spring Harbor Laboratory


Page: 1

Related biology news :

1. Mouse brain tumors mimic those in human genetic disorder
2. Researchers add new tool to tumor-treatment arsenal
3. Self-assembled nano-sized probes allow Penn researchers to see tumors through flesh and skin
4. Pulsating ultrasound enhances gene therapy for tumors
5. Scientists identify molecule that regulates well-known tumor suppressor
6. New tumor-suppressor gene discovered
7. NSAID drug protects against intestinal tumors in mice, despite poor diet and gene losses
8. Natural tumor suppressor in body discovered by UCSD medical researchers
9. Unexpected lock and key mechanism found for the assembly of tumor blood vessels
10. Nanoparticles carry cancer-killing drugs into tumor cells
11. New lead reported in tumor angiogenesis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/15/2016)... FREMONT, Calif. , Dec. 15, 2016   ... a publicly held genomics technology company, announced today that ... the Listing Qualifications Department of The Nasdaq Stock Market ... the closing bid price of WaferGen,s common stock had ... days.  Accordingly, WaferGen has regained compliance with Listing Rule ...
(Date:12/12/2016)... 12, 2016  Researchers at Trinity College, Dublin, ... by combining the material with Silly Putty. The mixture ... detector able to sense pulse, blood pressure, respiration, ... The research team,s findings were ... here:  http://science.sciencemag.org/content/354/6317/1257 ...
(Date:12/7/2016)... Dec. 7, 2016   Avanade is helping ... One teams in history, exploit biometric data in order ... and maintain the competitive edge against their rivals after ... Avanade has worked with Williams during the ... biometric data (heart rate, breathing rate, temperature and peak ...
Breaking Biology News(10 mins):
(Date:1/11/2017)... Linda, Ca (PRWEB) , ... January 11, 2017 ... ... resistance in pathogens are observed in clinical settings, it is becoming increasingly clear ... problem. An over-reliance on culture-based methods, the standard in the study of clinical ...
(Date:1/11/2017)... ... January 11, 2017 , ... For many fledging startups, good ... challenges young businesses face. With the second installment of Quorum’s newest signature program, ... DiMasi, Founder and Principal of interactive design agency, P’unk Ave. , For ...
(Date:1/11/2017)... ... January 11, 2017 , ... Advanced ... joined its team. Bernhard Bartylla will lead European initiatives for APMT’s product lines ... introduce ACOMP and ARGEN to European manufacturers and researchers. Bernhard brings significant experience ...
(Date:1/11/2017)...  GenVec, Inc. (NASDAQ: GNVC ), ... its chief scientific officer, Douglas E. Brough ... for translational development of innovative gene and cell ... Phacilitate Cell & Gene Therapy World 2017 Conference ... Brough,s presentation will highlight the utility of the ...
Breaking Biology Technology: